These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 24093175)
1. Targeted therapies in rare sarcomas: IMT, ASPS, SFT, PEComa, and CCS. Stacchiotti S; Marrari A; Dei Tos AP; Casali PG Hematol Oncol Clin North Am; 2013 Oct; 27(5):1049-61. PubMed ID: 24093175 [TBL] [Abstract][Full Text] [Related]
2. Genetics of rare mesenchymal tumors: implications for targeted treatment in DFSP, ASPS, CCS, GCTB and PEComa. Rutkowski P; Przybył J; Świtaj T Int J Biochem Cell Biol; 2014 Aug; 53():466-74. PubMed ID: 24704529 [TBL] [Abstract][Full Text] [Related]
3. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma. Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289 [TBL] [Abstract][Full Text] [Related]
4. [Medical treatment of soft tissue sarcomas based on the histological subtype]. Pápai Z Magy Onkol; 2014 Mar; 58(1):53-8. PubMed ID: 24712007 [TBL] [Abstract][Full Text] [Related]
5. Targeted therapies for sarcomas: new roles for the pathologist. Al-Zaid T; Somaiah N; Lazar AJ Histopathology; 2014 Jan; 64(1):119-33. PubMed ID: 24117526 [TBL] [Abstract][Full Text] [Related]